Abstract:AIM:To establish a mice model of hepatitis B by using HBV-transgenic mice, and to transfer HBV-specific cytotoxic T lymphocytes (CTL) induced from syngeneic BALB/c mice immunized by a eukaryotic expression vector containing HBV complete genome DNA.METHODS:HBV DNA was obtained from digested pBR322-2HBV and ligated with the vector pcDNA3. Recombinant pcDNA3-HBV was identified by restriction endonuclease assay and transfected into human hepatoma cell line HepG2 with lipofectin. ELISA was used to detect the expression of HBsAg in culture supernatant, and RT-PCR to determine the existence of HBV PreS1 mRNA. BALB/c mice were immunized with pcDNA3-HBV or pcDNA3 by intramuscular injection. ELISA was used to detect the expression of HBsAb in serum. MTT assay was used to measure non-specific or specific proliferation ability and specific killing activity of spleen lymphocytes. Lymphocytes from immunized mice were transferred into HBV-transgenic mice (2.5X10(7) per mouse). Forty-eight hours later, the level of serum protein and transaminase was detected with biochemical method, liver and kidney were sectioned and stained by HE to observe the pathological changes.RESULTS:By enzyme digestion with Eco RI, Xho I and Hind III, the recombinant pcDNA3-HBV was verified to contain a single copy of HBV genome, which was inserted in the positive direction. HepG2 cells transfected with the recombinant could stably express PreS1 mRNA and HBsAg. After immunized by pcDNA3-HBV for 4 weeks, HBsAb was detected in the serum of BALB/c mice. The potential of spleen lymphocytes for both non-specific and specific proliferation and the specific killing activity against target cells were enhanced. The transgenic mice in model group had no significant changes in the level of serum protein but had an obvious increase of ALT and AST. The liver had obvious pathological changes, while the kidney had no evident damage.CONCLUSION:A eukaryotic expression vector pcDNA3-HBV containing HBV complete genome is constructed successfully. HepG2 cells transfected with the recombinant can express PreS1 mRNA and HBsAg stably. Specific cellular immune response can be induced in mice immunized by pcDNA3-HBV. A mice model of acute hepatitis with HBV has been established.

Establishment of the Transgenic Mice Expressing the HBV Receptor Human ASGPR

Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome

Establishment of Mice Model with Human Viral Hepatitis B

[Generation of a Novel HBeAg Transgenic Mice Using CRISPR/Cas9 Technique].

Preliminary Study on the Production of Transgenic Mice Harboring Hepatitis B Virus X Gene.

Establishment of transgenic mice which express SARS coronavirus functional receptor human ACE2

Establishment of Mouse Model Harboring Hepatitis B Virus X Gene by the Means of Hydrodynamic Injection

Establishment of Human Interferon-Alpha Transgen- Ic Mice Model

Establishment of Transgenic Mice Carrying the Gene of Human Nuclear Receptor NR5A2 (Hb1f)

Cloning of HBx, Ras Gene and Preliminary Study on Establishing Transgenic Mice by Transfection of Spermatogonial Cells

Establishment of Hamster- and Human-Prnp Transgenic Mice.

Expression of Hepatitis B Virus Pres 2 Protein in Transgenic Mice Liver

Generation of Transgenic Mice with Liver-Specific Expression of Human Nuclear Receptor Nr5a2.

Functional Assessment of Expression of Cre Recombinase Targeting the Liver of Transgenic Mice Regulated by Tet-on and Cre/loxP System

[Establish a Transgenic Mice Model Harboring Structural Genes of Hepatitis C Virus].

Expression of HBV-X Gene Induced by Lentiviral Vector in Mice

Establishment of transgenic mouse models expressing human HSP22 protein

Generation of conditionally controlled transgenic mice expressing hepatitis C virus NS3/4A protease

Production of transgenic mouse harboring full-length hepatitis G virus genome

Establishment and Primary Application of a Mouse Model with Hepatitis B Virus Replication.

Establishment of a human APOA1 transgenic mouse model